Product Information
ALOSETRON HCL 0.5 MG TABLET is a generic product labeled by Lifestar Pharma LLC, priced at $2.0186 per EA under NDC 70756070230. Its NADAC has been published 301 times since Dec 30, 2020.
FDA first approved this application on Sep 9, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756070230
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALOSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213614FDA Approved
9/9/2020
TE Code
AB
On Market Since
9/14/2020
Pharmacological Classes
Price Statistics
The NADAC for ALOSETRON HCL 0.5 MG TABLET has been published 301 times since Dec 30, 2020, and over the history we have for it it has declined 83.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0186 per EA |
|---|---|
| All-time high | $12.4228 (Jan 13, 2021) |
| All-time low | $1.9260 (Jul 17, 2024) |
| 52-week high | $2.5631 |
| 52-week low | $1.9490 |
| Median price | $2.7639 |
| Average price | $3.4483 |
| Largest weekly change | -56.2% (Jun 23, 2021) |
| Weeks tracked | 301 |
| Tracking since | Dec 30, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Alosetron market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alosetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALOSETRON HCL 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALOSETRON HCL 0.5 MG TABLET, manufactured by Lifestar Pharma LLC, is $2.0186 per EA (NDC 70756070230), effective Sep 30, 2026.
How has the price of ALOSETRON HCL 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALOSETRON HCL 0.5 MG TABLET has declined 83.8%. It has been tracked across 301 weekly CMS publications since Dec 30, 2020.
What are the highest and lowest recorded NADAC prices for ALOSETRON HCL 0.5 MG TABLET?
Since Dec 30, 2020, the NADAC for ALOSETRON HCL 0.5 MG TABLET has ranged from a low of $1.9260 (Jul 17, 2024) to a high of $12.4228 (Jan 13, 2021), with a median of $2.7639 per EA.
Are there cheaper alternatives to ALOSETRON HCL 0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ALOSETRON HCL 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALOSETRON HCL 0.5 MG TABLET?
ALOSETRON HCL 0.5 MG TABLET (NDC 70756070230) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.